Site-specific transgene integration in the human genome catalyzed by φBT1 phage integrase

Human Gene Therapy

Volumn 19, Issue 2, 2008, Pages 143-151

  Chen, Li ^a   Woo, Savio L C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INTEGRASE; PHENYLALANINE 4 MONOOXYGENASE; PHI BT 1 INTEGRASE; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA INTEGRATION; GENE IDENTIFICATION; GENOME; HUMAN; HUMAN CELL; KARYOTYPE; LIVER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; STREPTOMYCES;

ATTACHMENT SITES, MICROBIOLOGICAL; BACTERIOPHAGES; BASE SEQUENCE; BETA-GALACTOSIDASE; CATALYSIS; CELL LINE; CHROMOSOMES, HUMAN; GENOME, HUMAN; HUMANS; INTEGRASES; KINETICS; MOLECULAR SEQUENCE DATA; PLASMIDS; RECOMBINATION, GENETIC; TRANSGENES; VIRUS INTEGRATION;

BACTERIA (MICROORGANISMS); MAMMALIA; MURINAE; MUS; STREPTOMYCES;

EID: 39449129566     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2007.110     Document Type: Article

References (30)

1. ALLEN, B.G., and WEEKS, D.L. (2005). Transgenic Xenopus laevis embryos can be generated using φC31 integrase. Nat. Methods 2, 975-979.
2. BELTEKI, G., GERTSENSTEIN, M., OW, D.W., and NAGY, A. (2003). Site-specific cassette exchange and germline transmission with mouse ES cells expressing φC31 integrase. Nat. Biotechnol. 21, 321-324.
3. CALOS, M.P. (2006). The φC31 integrase system for gene therapy. Curr. Gene Ther. 6, 633-645.
4. CHALBERG, T.W., GENISE, H.L., VOLLRATH, D., and CALOS, M.P. (2005). φC31 integrase confers genomic integration and long-term transgene expression in rat retina. Invest. Ophthalmol. Vis. Sci. 46, 2140-2146.
5. CHALBERG, T.W., PORTLOCK, J.L., OLIVARES, E.C., THYAGARAJAN, B., KIRBY, P.J., HILLMAN, R.T., HOELTERS, J., and CALOS, M.P. (2006). Integration specificity of phage φC31 integrase in the human genome. J. Mol. Biol. 357, 28-48.
6. CHEN, L., and WOO, S.L. (2005). Complete and persistent phenotypic correction of phenylketonuria in mice by site-specific genome integration of murine phenylalanine hydroxylase cDNA. Proc. Natl. Acad. Sci. U.S.A. 102, 15581-15586.
7. EHRHARDT, A., ENGLER, J.A., XU, H., CHERRY, A.M., and KAY, M.A. (2006). Molecular analysis of chromosomal rearrangements in mammalian cells after φC31-mediated integration. Hum. Gene Ther. 17, 1077-1094.
8. GINSBURG, D.S., and CALOS, M.P. (2005). Site-specific integration with φC31 integrase for prolonged expression of therapeutic genes. Adv. Genet. 54, 179-187.
9. GROTH, A.C., OLIVARES, E.C., THYAGARAJAN, B., and CALOS, M.P. (2000). A phage integrase directs efficient site-specific integration in human cells. Proc. Natl. Acad. Sci. U.S.A. 97, 5995-6000.
10. GROTH, A.C., FISH, M., NUSSE, R., and CALOS, M.P. (2004). Construction of transgenic Drosophila by using the site-specific integrase from phage φC31. Genetics 166, 1775-1782.
11. HELD, P.K., OLIVARES, E.C., AGUILAR, C.P., FINEGOLD, M., CALOS, M.P., and GROMPE, M. (2005). In vivo correction of murine hereditary tyrosinemia type I by φC31 integrase-mediated gene delivery. Mol. Ther. 11, 399-408.
12. HOLLIS, R.P., STOLL, S.M., SCLIMENTI, C.R., LIN, J., CHENTSAI, Y., and CALOS, M.P. (2003). Phage integrases for the construction and manipulation of transgenic mammals. Reprod. Biol. Endocrinol. 1, 79.
13. ISHIKAWA, Y., TANAKA, N., MURAKAMI, K., UCHIYAMA, T., KUMAKI, S., TSUCHIYA, S., KUGOH, H., OSHIMURA, M., CALOS, M.P., and SUGAMURA, K. (2006). Phage φC31 integrase-mediated genomic integration of the common cytokine receptor gamma chain in human T-cell lines. J. Gene Med. 8, 646-653.
14. KERAVALA, A., GROTH, A.C., JARRAHIAN, S., THYAGARAJAN, B., HOYT, J.J., KIRBY, P.J., and CALOS, M.P. (2006). A diversity of serine phage integrases mediate site-specific recombination in mammalian cells. Mol. Genet. Genomics 276, 135-146.
15. KITAJIMA, K., MARCHADIER, D.H., MILLER, G.C., GAO, G.P., WILSON, J.M., and RADER, D.J. (2006). Complete prevention of atherosclerosis in apoE-deficient mice by hepatic human apoE gene transfer with adeno-associated virus serotypes 7 and 8. Arterioscler. Thromb. Vasc. Biol. 26, 1852-1857.
16. LIU, J., JEPPESEN, I., NIELSEN, K., and JENSEN, T.G. (2006). φc31 integrase induces chromosomal aberrations in primary human fibroblasts. Gene Ther. 13, 1188-1190.
17. LUTZ, K.A., CORNEILLE, S., AZHAGIRI, A.K., SVAB, Z., and MALIGA, P. (2004). A novel approach to plastid transformation utilizes the φC31 phage integrase. Plant J. 37, 906-913.
18. MALLA, S., DAFHNIS-CALAS, F., BROOKFIELD, J.F., SMITH, M.C., and BROWN, W.R. (2005). Rearranging the centromere of the human Y chromosome with φC31 integrase. Nucleic Acids Res. 33, 6101-6113.
19. O'GORMAN, S., FOX, D.T., and WAHL, G.M. (1991). Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 251, 1351-1355.
20. OLIVARES, E.C., HOLLIS, R.P., and CALOS, M.P. (2001). Phage R4 integrase mediates site-specific integration in human cells. Gene 278, 167-176.
21. ORTIZ-URDA, S., THYAGARAJAN, B., KEENE, D.R., LIN, Q., CALOS, M.P., and KHAVARI, P.A. (2003). φC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa. Hum. Gene Ther. 14, 923-928.
22. PORTLOCK, J.L., KERAVALA, A., BERTONI, C., LEE, S., RANDO, T.A., and CALOS, M.P. (2006). Long-term increase in mVEGF164 in mouse hindlimb muscle mediated by phage φC31 integrase after nonviral DNA delivery. Hum. Gene Ther. 17, 871-876.
23. QUENNEVILLE, S.P., CHAPDELAINE, P., ROUSSEAU, J., BEAULIEU, J., CARON, N.J., SKUK, D., MILLS, P., OLIVARES, E.C., CALOS, M.P., and TREMBLAY, J.P. (2004). Nucleofection of muscle-derived stem cells and myoblasts with φC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts. Mol. Ther. 10, 679-687.
24. SAUER, B. (1994). Site-specific recombination: Developments and applications. Curr. Opin. Biotechnol. 5, 521-527.
25. SMITH, M.C., and THORPE, H.M. (2002). Diversity in the serine recombinases. Mol. Microbiol. 44, 299-307.
26. STOLL, S.M., GINSBURG, D.S., and CALOS, M.P. (2002). Phage TP901-1 site-specific integrase functions in human cells. J. Bacteriol. 184, 3657-3663.
27. THOMASON, L.C., CALENDAR, R., and OW, D.W. (2001). Gene insertion and replacement in Schizosaccharomyces pombe mediated by the Streptomyces bacteriophage φC31 site-specific recombination system. Mol. Genet. Genomics 265, 1031-1038.
28. THYAGARAJAN, B., OLIVARES, E.C., HOLLIS, R.P., GINSBURG, D.S., and CALOS, M.P. (2001). Site-specific genomic integration in mammalian cells mediated by phage φC31 integrase. Mol. Cell. Biol. 21, 3926-3934.
29. VAN DER WEGEN, P., LOUWEN, R., IMAM, A.M., BUIJSOFFERMAN, R.M., SINAASAPPEL, M., GROSVELD, F., and SCHOLTE, B.J. (2006). Successful treatment of UGT1A1 deficiency in a rat model of Crigler-Najjar disease by intravenous administration of a liver-specific lentiviral vector. Mol. Ther. 13, 374-381.
30. YANG, H.Y., KIM, Y.W., and CHANG, H.I. (2002). Construction of an integration-proficient vector based on the site-specific recombination mechanism of enterococcal temperate phage φFC1. J. Bacteriol. 184, 1859-1864.